BSX vs TROW · P/E 20, rev $10.65B vs P/E 12, rev $3.76B
Boston Scientific Corp (BSX) versus T. Rowe Price Group Inc (TROW) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
T. Rowe Price Group Inc (TROW) is a asset management company listed on NASDAQ.
Latest reported BSX revenue for 2026-06-30 was $10.65B. Net income was $2.24B. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported TROW revenue for 2026-06-30 was $3.76B. Net income was $1.13B. TROW currently screens at market cap $23.17B and trailing P/E 11.6.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. TROW currently screens at market cap $23.17B and trailing P/E 11.6.
Not investment advice. Open the BSX and TROW stock pages for the full models.
Not investment advice.